Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Validation of a Mass Spectrometry-Based Proteomics Molecular Pathology Assay.
Journal: Molecular & cellular proteomics : MCP
Published: April 23, 2025
Mass Spectrometry-Based Proteomics for the Masses: Peptide and Protein Identification in the Hunt Laboratory During the 2000's.
Journal: Molecular & cellular proteomics : MCP
Published: August 24, 2024
Tissue Mass Spectrometry: How Solid Is Our Future?
Journal: Clinical chemistry
Published: April 01, 2023
Developing a meta-understanding of 'human aspects' of providing palliative care.
Journal: Palliative care and social practice
Published: October 14, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 05, 2021
Localized Peritumoral AL Amyloidosis Associated With Mantle Cell Lymphoma With Plasmacytic Differentiation.
Journal: The American journal of surgical pathology
Published: March 19, 2021
The cell envelope of Staphylococcus aureus selectively controls the sorting of virulence factors.
Journal: Nature communications
Published: October 27, 2020
Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: September 02, 2020
Tracking of low disease burden in multiple myeloma: Using mass spectrometry assays in peripheral blood.
Journal: Best practice & research. Clinical haematology
Published: December 17, 2019
Fibrinogen alpha amyloidosis: insights from proteomics.
Journal: Expert review of proteomics
Published: August 25, 2019
Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple Myeloma.
Journal: The Journal of molecular diagnostics : JMD
Published: July 31, 2019
Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis.
Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis.
Journal: Haematologica
Published: September 29, 2018
Last Updated: 09/26/2026